TrivarX Limited (MDBIF)

Market Cap	18.72M +293.5%
Revenue (ttm)	-63.61K +16.0%
Net Income	-1.41M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Open	0.0026
Previous Close	0.0025
Day's Range	0.0026 - 0.0026
52-Week Range	0.0025 - 0.0244
Beta	0.86
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About TrivarX

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1987
• Employees: 6
• Stock Exchange: OTCMKTS
• Ticker Symbol: MDBIF

Financial Performance

In fiscal year 2025, TrivarX's revenue was 1.03 million, an increase of 16.00% compared to the previous year's 888,829. Losses were -943,231, -34.25% less than in 2024.

Financial numbers in AUD